Abstract -The acute phase protein 1 -acid glycoprotein (AGP -Orosomucoid) is a lipocalin with immunomodulatory functions. The present study provides evidence that the plasma glycoforms of AGP inhibit the migration of bovine monocytes in response to classical chemoattractants. The inhibition is specific, since neutrophils are apparently not affected. To investigate the molecular basis of this finding, the expression of the molecules mostly involved in chemotaxis, including CD18, CD11b and CD47 was studied. It was found that the incubation of activated monocytes with acute phase concentration of AGP (0.9 mg/mL) induces a down-regulation of CD18, and has no apparent influence on CD11b and CD47. RT-PCR expression studies on CD18, CD11b and CD47 mRNA revealed that AGP treatment does not modify the expression rate of these genes. Since AGP treatment is related to a down-regulation of CD18 on the surface of the monocytes, the authors suggest that one of its possible functions consists in specifically reducing the firm adhesion phase of bovine monocytes to the endothelium. alpha-1 acid glycoprotein / acute phase protein / CD18 / monocytes / chemotaxis
INTRODUCTION
Inflammation is a crucial response to tissue injury and host defences against invading microbes and tissue damage. An affected tissue accumulates leukocytes, which contribute to the inflammatory response by secreting cytotoxic and pro-inflammatory compounds, and by activating their phagocytic activity together with targeted attacks against foreign agents. The control of leukocyte efflux from the circulation, partially mediated by endothelial and leukocyte adhesion receptors, is important in regulating inflammation [21, 40] . A typical leukocyte chemotaxis consists of different phases: (i) tethering or capturing; -subunit. At present four 2 integrins have been identified: CD11a/CD18 (LFA-1), CD11b/CD18
(MAC-1), CD11c/CD18 (p150/95) and CD11d/CD18 [15] . The involvement of the CD18 subunit in chemotaxis has been evidenced in humans and bovines by leukocyte adhesion deficiency (LAD). This phagocytic disease originates from mutations in the CD18 gene, which predisposes to life-threatening infections, caused by impaired intravascular adhesion, transendothelial migration, phagocytosis and target cell killing [2, 24] .
CD47 (also known as integrin-associated protein or IAP) is an immunoglobulin superfamily member involved in leukocyte transmigration across the epithelia and endothelia. CD47 can modulate cell adhesion, cooperating with 2 integrins CD11b/CD18, and subsequent migration stages, resulting in rapid opening and closing of tight junctions to allow the passage of cells and the preservation of the epithelial barrier [26, 29] . CD47 is ubiquitously expressed on the plasma membrane [30] , and anti-CD47 antibodies have been shown to potently inhibit neutrophil transmigration [22] . The presence and importance of CD47 in the migration of bovine neutrophils (PMN) were recently demonstrated by Lamote et al. [20] .
Pro-inflammatory cytokines produced by leukocytes and endothelial cells during inflammation induce a reorganization of the gene expression pattern of hepatocytes, thus causing an up-regulation of the synthesis of a family of structurally unrelated proteins, the Acute Phase Proteins (APP). From a clinical perspective, alpha-1 acid glycoprotein (AGP) acts as a minor APP in humans and domestic animals, since its concentration is increased up to 3-5 fold during inflammation [16, 27] . AGP is mainly produced by hepatic cells: extra-hepatic expression has even been reported in other tissues, such as in white blood cells, including cultured human monocytes [25, 31] , and in resting or activated polymorphonuclear leukocytes, all able to develop an immunological barrier providing a rapid defence against additional damage caused by inflammation [6, 27, 28, 38] . While being one of the most important binding proteins in plasma [17] , AGP also features several immunomodulatory functions [16] , such as, for example, the stimulation of human monocytes to release pro-and anti-inflammatory cytokines [36] , the inhibition of the chemotactic response of human neutrophils challenged with formyl-methionyl-leucyl-phenylalanine (fMLP) [19, 41] and the reduction of platelet aggregation [35] . Moreover, AGP is capable of protecting cells from apoptosis induced by inflammation [7] [8] [9] . In this study it was first hypothesized that AGP may modulate the chemotactic response of bovine defensive cells, including monocytes and polymorphonuclear cells. In the second part of the investigation, it was hypothesized that ideal targets of AGP activity were the surface molecules mostly involved in chemotactic migration, which include 2 -integrins and CD47. Before this study was carried out, the binding of AGP on the surface of monocytes and granulocytes was examined.
MATERIALS AND METHODS

Materials
Reagents
Zymosan A from Saccharomices cerevisiae, human recombinant IL-8 expressed in Escherichia coli, HEPES, EDTA, RPMI-1640, Red Blood Cell Lysing Buffer Hybri-Max™, Percoll, PBS without Ca 2+ and Mg 2+ and endotoxin-free water were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Fetal Bovine Serum was provided by Biochrom AG (Berlin, Germany) and Ficoll 1077 by GE Healthcare Europe GmbH (Munich, Germany). Chemotaxis chamber and PVP-free polycarbonate filter were purchased from NeuroProbe ® (Gaithersburg, MD, USA), Diff-Quick from Medion Diagnostics (Düdingen, Switzerland). Macs ® Separation Columns and CD14 Microbeads were purchased from MiltenyiBiotech (Auburn, CA, USA), the RNeasy Mini Kit from Qiagen GmbH (Hiden, Germany), iScript™ cDNA Synthesis Kit and SYBR ® Green mix from Biorad (Hercules, CA, USA).
AGP was obtained from healthy bovine serum following the chromatographic purification protocol previously established [7] . The final endotoxin level was measured using Limulus amebocyte lysate (LAL) (BioWhittaker, Walkersville, MD, USA). RhIL-8 was reconstituted in endotoxin-free water. Before use, ZAS was passed through a 0.22 m filter provided by Millipore (Billerica, MA, USA). Chromatin DNA stained DAPI was purchased from Molecular Probes ® Europe BV (Leiden, Netherlands) and anti-fade medium from Vectashild (Burilngame, CA, USA).
Mouse anti-human CD47 (clone BRIC 126), which cross reacts with bovine CD47 [20] , mouse anti-bovine CD11b (clone CC126) and their irrelevant control mouse antibody IgG2B; mouse anti-canine CD18 (clone CA1.4E9), which cross reacts with bovine CD18 [3] , and its irrelevant control mouse antibody IgG1, secondary antibody polyclonal rabbit anti-mouse IgG-FITC were purchased from Serotec (Oxford, UK) and resuspended in endotoxin-free PBS; goat antimouse IgG1-FITC IgG2b-PE were purchased from Santa Cruz Biotechnology ® (Santa Cruz, CA, USA). The maximal inhibitory dose of each antibody was determined in initial dose-response experiments.
Polyclonal rabbit anti-bovine AGP was used as described [7] ; the secondary antibody donkey anti-rabbit IgG-FITC was purchased from Jackson Immunoresearch lab (West Grove, PA, USA).
Source and purification of monocytes and polymorphonuclear cells from bovine blood
Bovine monocyte (CD14 + cells) isolation was carried out as previously described [7] with some modifications. Clinically healthy multiparous lactating cows (Holstein Friesians) between three and eight years of age, and between four and ten weeks after calving were used for blood collection. Blood was collected by jugular venipuncture into sterile tubes containing 3.2% sodium citrate as an anticoagulant and was processed within one hour of collection. Buffy coat, obtained by centrifugation at 1 260 × g for 30 min at room temperature, was diluted 1:5 (vol/vol) in PBS with 2 mM EDTA, and 10 mL of this solution were overlaid on 3 mL Ficoll 1077 and centrifuged for 30 min at 1 500 × g at 4
• C. Mononuclear cells were collected from the interface. The cells were resuspended in 50 mL PBS with 2 mM EDTA and centrifuged for 7 min at 400 × g at 4
• C in order to remove platelets. This step was repeated four times. Remaining red blood cells were lysed with Red Blood Cell Lysing Buffer Hybri-Max. Monocyte (CD14 + ) cell isolation was carried out using magnetic activated cellular sorting (MACS). Briefly, PBMC were incubated with anti-human CD14 labeled super-paramagnetic beads (20 L/10 8 cells) for 15 min at 4
• C and CD14 + cells were isolated from a MidiMacs column according to the manufacturer's instructions. The purity of the sorted cells (> 98%) was evaluated by flow cytometry. Cell viability, as determined by Trypan Blue exclusion, was > 95%. The concentration of monocytes was adjusted to 1.5 × 10 6 /mL in migration medium with 1% heat inactivated FBS (see below).
Bovine neutrophils were isolated as described [5, 34] after partial modifications. Blood samples were collected from six cows as described above; samples containing less than 5% of eosinophils were used. Blood was centrifuged at 1 000 × g for 30 min at 4
• C; the plasma, buffy coat and top one-third of the red blood cell pellet were aspirated. The remainder of the pellet containing PMN was diluted 1:3 (vol/vol) in cold PBS, gently layered on 10 mL Percoll 1.087 g/mL and centrifuged at 400 × g for 40 min at room temperature. After the removal of Percoll, the remaining red blood cells were removed by hypotonic lysis and neutrophils were washed four times with cold PBS. Cell viability, as determined by Trypan Blue exclusion, was > 95%. The concentration of neutrophils was adjusted to 1.5 × 10 6 /mL in migration medium with 10% heat inactivated FBS.
Media
The AGP and rhIL-8 were diluted in migration medium (RPMI 1640 with 20 mM HEPES and 1% or 10% heat inactivated FBS for monocytes and neutrophils respectively).
Bovine serum was activated with 15 mg/mL of Zymosan A at 37
• C for 60 min. The mixture was then incubated at 56
• C for 30 min to destroy complement components with the exception of C5a. Zymosan particles were removed by centrifuging the mixture for 15 min at 1 000 × g at 4
• C. The supernatant obtained was filtered through a 0.22 m filter membrane, stored at −80
• C and used within three months. For migration assay the ZAS stock solution was diluted 1:5 (vol/vol) with migration medium.
The cells were incubated in the presence of chemoattractants: ZAS was used for monocytes and either ZAS or rhIL-8 (100 ng/mL, final concentration) for neutrophils [43] . The activated cells were then cultured with two different concentrations of purified AGP: precisely at low concentration similarly to bovine plasma in healthy subjects (0.3 mg/mL), and at high concentration similarly to bovine plasma at acute phase reaction (0.9 mg/mL) [11, 37] . Monocytes and neutrophils were incubated at 37
• C for 2 h and 30 min, respectively.
All the experiments were carried out by running control samples in parallel, in which AGP was replaced by medium. After incubation, the cells were centrifuged at 500 × g for 7 min at 4
• C and suspended in migration medium without chemoattractants and protein.
Migration assay
Cell migration was evaluated using a microchamber technique as previously described [12] . Twenty-seven microliters of chemoattractant solution or migration medium (with 1% or 10% heat inactivated FBS for monocytes and neutrophils respectively) were added to the lower wells of a 48-well chemotaxis chamber. Assays were made in triplicate. A PVP-free polycarbonate filter (5 m pore size) [42] was layered onto the wells and covered with a silicon gasket and the top plate. Fifty microliters of cell suspension (1.5 × 10 6 cells/mL) were seeded in the upper chamber. The chamber was incubated at 37
• C in 5% CO 2 for 75 min for neutrophils and for 105 min for monocytes. At the end of incubation, the filters were removed and stained with Diff-Quick and ten high-power oil-immersion fields were counted.
Flow cytometry analysis
Indirect cell staining was performed. Neutrophils and monocytes were incubated with saturating amounts of primary antibodies, mouse anti-human CD47 or its irrelevant control mouse antibody IgG2b to eliminate non specific binding; mouse anti-bovine CD11b or its irrelevant control mouse antibody IgG2b and mouse anti-canine CD18 or its irrelevant control mouse antibody IgG1. Isolated cells (5 × 10 5 ) were suspended in sterile PBS with 1% FBS and incubated with primary antibody for 30 min at 4
• C. After incubation, cells were centrifuged at 500 × g for 8 min at 4
• C, washed twice with excess of cold PBS with 1% FBS and labeled for 30 min at 4
• C in the dark with secondary antibody polyclonal rabbit anti-mouse IgG-FITC for neutrophils and goat anti-mouse IgG1-FITC or IgG2b-PE for monocytes. The cells were then centrifuged at 500 × g for 8 min at 4
• C, washed, stabilized with 1% formalin in PBS and kept at 4
• C until flow cytometric analysis. Cells (1 × 10 4 events) were analyzed on a FACS Calibur cytometry system (Becton Dickinson, Mountain View, CA, USA) calibrated with Calibrite beads (Becton Dickinson).
mRNA expression
Total RNA was extracted from stimulated monocytes using the RNeasy Mini Kit according to the manufacturer's protocol. The reverse transcription (RT) reaction was carried out on 1 g RNA using an iScript™ cDNA Synthesis Kit. The thermal profile was as protocol suggesting. Quantitative reactions were performed in 25 L of SYBR ® Green mix and 400 nM of CD47 primers (sense-GCTGGACTACTGCTCACTGTC and antisense-GAGGACATCCCCATAGCTATC) and GAPDH primers (sense-GGCGTGAACCACGAGAAGTA TAA and antisense-CCCTCCACGATGCCAA AGT) and 450 nM of CD11b primers (sense-GAGGCACTGTGATGCTGTCC and antisense-GCCTGTCCCCATTCACATCC) and CD18 primers (sense-CCTCAATGGCATCACCGAGTC and antisense-TGACGAAGGGGAGCACCG). Each sample was tested in duplicate. In order to evaluate the PCR efficiency, series of dilution were prepared by performing fourfold serial dilution starting from the reference samples. The thermal profile used (95
• C for 90 s, 50 cycles of 95
• C for 15 s and 60
• C for 60 s; for melting curve construction, 55
• C for 60 s and 80 cycles starting to 55
• C and increasing 0.5
• C each 10 s) was the same for each target gene. The results obtained were compared using the delta-delta Ct method [14] .
Immunocytochemistry studies related to AGP binding to bovine monocytes
In order to verify if the activated bovine monocytes were capable of binding AGP on the membrane surface, 1.5 × 10 5 monocytes were stimulated for 2 h with or without ZAS and AGP (0.3 mg/mL or 0.9 mg/mL). The cells were centrifuged at 500 × g for 8 min at 4
• C, washed two times with cold sterile PBS in order to remove stimulation medium and stabilized with 1% formalin. The cells were allowed to settle on a glass slide and processed to assess AGP localization by immunofluorescence. After an incubation of 30 min at 26
• C in non-sterile PBS containing 1% BSA and 1% NDS (Normal Donkey Serum), the slides were incubated overnight at 4
• C with a polyclonal rabbit anti-bovine AGP (17 g/mL in DPBS) [9] . After the incubation, the samples were washed twice in PBS and stained with a fluorescein isothiocyanate (FITC) conjugated donkey anti-rabbit IgG antibody (1:200) for 30 min at 26
• C. Chromatin DNA was stained with DAPI (0.05 g/mL in PBS).
As the control, the primary antibody against AGP was omitted from one slide for each experiment. All samples were mounted with an anti-fade medium and observed with a conventional epifluorescence microscope (Nikon, Eclipse E 600).
Statistical analysis
For all statistical procedures, mean and standard error of the mean values were computed using statistical software (SPSS 15.0, SPSS Inc., Chicago, USA). Different treatments were compared using a non parametric Wilcoxon test for paired samples. Statistical significance was accepted at P < 0.05.
RESULTS
The quality of AGP
The protein that was used throughout all the experiments presented hereby was purified from blood as described in the Materials and Methods section. The endotoxin level in AGP used in the present study was < 0.05 ng/mg of protein, a value compatible with in vivo experiments with monocytes and neutrophils. Analysis of AGP by SDS-PAGE followed by Commassie Brilliant blue staining revealed (i) a single band of ∼43 kDa; and (ii) homogeneity in the protein fraction, used to perform all the experiments in this paper (data not shown).
Effect of AGP on monocyte and neutrophil chemotaxis
To determine whether AGP is involved in monocyte and neutrophil chemotaxis, freshly isolated bovine monocytes and neutrophils were stimulated with AGP at physiological (0.3 mg/mL) or acute phase (0.9 mg/mL) concentration for 2 h and 30 min respectively. The chemotactic media were subsequently tested for monocyte and neutrophil migration in a modified Boyden chamber assay, where the cells were allowed to migrate across a membrane. As positive control, ZAS only was used for monocytes, while either ZAS or rhIL-8 was employed for neutrophils (Fig. 1) . The results show that the migration of monocytes was modified by AGP at both low and high concentrations: as shown in Figure 1A , monocyte migration rate was significantly reduced when the cells were pre-incubated with AGP at both low and high concentrations and chemotactic medium contained only ZAS (P < 0.01). Similar results were obtained when the pre-incubated cells migrated to the chemotactic medium including ZAS and AGP at physiological dose. A further decrease of migration was observed when high concentration of AGP was added to the chemotactic medium with ZAS (P < 0.001). No modification in neutrophil migration was observed when either ZAS or rhIL-8 (Fig. 1B) was used as challengers.
Influence of AGP on CD11b, CD18
and CD47 expression on monocyte and neutrophil surface
The expression of CD47 on the surface of bovine monocytes has not been under investigation so far, to the authors' best knowledge. In the present study, it was assessed by means of flow cytometry which resulted in a clear expression of CD47, as observed and shown in supplementary material (Fig. A available online only at www.vetres.org). The mean channel fluorescence (MCF) for CD47 was 220 ± 36 (mean ± SEM) after subtraction of fluorescence associated with the autofluorescence, isotype matched control and secondary antibody control. The mean value for CD11b (positive control) was 638 ± 100 (mean ± SEM).
Monocytes and neutrophils were treated with or without chemotaxis activator (ZAS Media with or without ZAS were used as positive or negative controls respectively. Each assay was carried out in triplicate. Data are means ± SEM of eight independent experiments. The presence of physiological (0.3 mg/mL) and acute phase (0.9 mg/mL) doses of AGP in cell stimulation media significantly reduced to negative control level monocyte migration ( * * P < 0.01) when compared with positive controls. A migration reduction was also observed when AGP at physiological concentration was present in chemotactic medium with ZAS ( * P < 0.05). A higher migration reduction was observed when AGP at pathological concentration was present in chemotactic medium with ZAS ( * * * P < 0.001). (B) Bovine neutrophil migration towards ZAS or rhIL-8. Media with or without ZAS or rhIL-8 were used as positive or negative controls respectively. Each assay was carried out in triplicate. Data are means ± SEM of six independent experiments. The AGP either at low (0.3 mg/mL) and high concentration (0.9 mg/mL) had no influence on the neutrophil migration.
for monocytes, and either ZAS or rhIL-8 for neutrophils) as positive and negative controls, respectively. AGP were added in the medium at low (0.3 mg/mL) or high (0.9 mg/mL) concentrations. Bovine monocytes exposed to AGP and ZAS for two hours revealed no significant influence as to the expression of CD11b and CD47 (Fig. 2) , while monocytes treated with ZAS and AGP at high concentration demonstrated a decreased expression of CD18 (P < 0.05) compared with monocytes treated with ZAS only with the evident uprising of a CD18 negative monocyte population. In a series of seven experiments, AGP caused a 25% decrease of MCF and an 18% decrease of CD18 positive cells (% gated). On the contrary, as seen in neutrophil migration experiments, neutrophils treated with rhIL-8/ZAS and AGP at high concentration showed no significant modification of CD47, CD11b and CD18 antigen surface expressions (Fig. 3) .
Expression of CD11b, CD18 and CD47 mRNA
To investigate whether AGP could influence not only the surface expression of CD11b, CD18 and CD47 antigens, but also the corresponding mRNA levels in monocytes, the expression of genes was clearly established by quantitative real-time PCR analysis of monocyte cDNA. The relative quantification of CD11b, CD18 and CD47 mRNA between control cells and stimulated cells was performed by the delta-delta Ct method after normalization of the sample using the GAPDH gene as the housekeeping gene. The results are shown in Figure 4 . In six different experiments, AGP did not cause any significant modification of CD11b, CD18 and CD47 gene expression.
AGP binding to the surface of monocytes
To investigate whether AGP binds directly to its target cells, both resting and stimulated monocytes were prepared and labeled for AGP immunoreactivity using the polyclonal anti-AGP antibody. The results are presented in Figure 5 . ZAS-activated monocytes reveal a low, homogeneous staining, located on the surface of the cells. Treating monocytes with high concentration of AGP resulted in an evident increase of anti-AGP immunoreactivity, thus suggesting that plasma AGP can bind to the surface of activated monocytes.
DISCUSSION
In this paper, we report for the first time that the acute phase protein 1 -acid glycoprotein is able to reduce the chemotaxis of bovine monocytes when used at high concentrations, similar to those found in plasma during a systemic response to inflammation. Remarkably, this inhibitory activity is both dose-dependent, the physiological concentration of AGP having no effect on chemotaxis, and cell-specific, since it does not affect neutrophils. This result was not consistent with what was observed in humans whose AGP can reduce PMN migration capability in a dose-dependent way [19, 41] .
Tissues react to injuries by a basic process, an acute inflammatory reaction that physiologically leads to repair and/or removal of the damaged tissues. Its hallmark consists in activating defensive cells hierarchically, whose sequence includes resident macrophages, migrated polymorphonuclear cells and, finally, intervening monocytes [31] .
The whole process, aimed at reducing unnecessary damages to nearby tissues, including both the influx of defensive cells and their lifespan, has to be tightly regulated. So far several proteins fulfilling this role have been characterized; many belong to the non structurally related family of acute phase proteins, among them AGP.
The biological significance of the involvement of AGP in the regulation of monocyte chemotaxis should be seen in the background of the activity of AGP on monocytes.
The so called mononuclear-phagocyte system plays a pivotal role in the inflammatory environment. Tissue resident macrophages are critical in triggering the inflammatory sequence by removing pathogens and producing pro-inflammatory cytokines. In a second inflammatory phase, intervening monocytesrecruited from blood due to pro-inflammatory signaling -become crucial in the resolution phase of inflammation thanks to the production of anti-inflammatory cytokines as well as the elimination of polymorphonuclear cells and tissue debris. AGP targets several monocyte/macrophage functions during inflammation, including the up-regulation of the expression of anti-inflammatory cytokines [39] and the increasing of their lifespan by reducing their apoptosis rate [7] . Therefore, the main function of AGP in the inflammatory focus converges toward an overall anti-inflammatory function, which is carried out by attenuating tissue damages related to uncontrolled activation of cells involved in the inflammatory process. In fact, given the reduction of the monocyte chemotaxis by AGP, potentially it might also increase the lifespan of neutrophils in the inflammatory focus, but this seemingly pro-inflammatory activity is poorly consistent with the other activities of AGP identified so far.
The possibility that this anti-chemotactic activity of AGP is directed toward a specific monocyte subpopulation should not be ruled out. Human monocytes have been further classified in different subsets, the CD16 − /CCR2 + monocytes [44] , which are recruited to tissues during inflammation, and CD16 + /CCR2 − , which migrate into tissues irrespective of inflammatory stimuli. This latter population exhibits surface antigens that resemble those of tissue macrophages, and, coherently, shows a higher antigen presenting cell activity and pronounced pro-inflammatory cytokine pattern. It should be interesting to investigate whether the AGP activity is targeted toward a specific monocyte subset. Unfortunately, while described in all the species investigated so far, which include the pig, mouse, rat and, of course, humans, the presence of the CD16 + /CD16 − population in bovines has yet to be demonstrated, since, at least to our knowledge, anti-CD16 antibodies specific for bovine cells are not available.
The anti-chemotactic activity of AGP against monocytes may also be seen in relation with the decreasing of milk-resident macrophages during early post-partum [18, 23] , since it was found that AGP increases its plasma level around peripartum [4] . Though interesting, this hypothesis must be carefully investigated, since it was reported that the expression of 2 -integrins on monocyte surface does not change during peripartum [10] .
In an attempt to explain the downregulation of monocyte chemotaxis at the molecular level, it was found that AGP causes a lowering of the net number of CD18 molecules on the monocyte surface, thus inducing the uprising of a new population of CD18 − monocytes. No effect has been shown on the expression of the integrin CD11b, the other twin component of MAC-1, as well as on CD47, a protein that can associate with and modulate the activity of several integrins [13] .
The explanation of these two populations of CD18 + and CD18 − is elusive. Conceivably, the logic outcome of the down-regulation of CD18 should be the reduction of the adhesion phase in the transendothelial migration sequence. Yet, this hypothesis has to be definitely confirmed by experiments that include endothelial cells into the culture scaffold, such as those previously reported [33] . Therefore, since our Boyden chamber experimental model excludes the interaction of CD18 with the adhesion molecules exposed on the surface of activated endothelium, it can be hypothesized that there is at least another mechanism that reduces the migration of monocytes, and that is not related to the interaction of CD18-adhesion molecules.
Indeed, the down-regulation of integrins on the surface of the cells by AGP not only does imply the reduction of the adhesion of monocytes to endothelial cells, but also the downgrading of several other activities involving where MAC-1 integrin is involved, including the clustering and association with cytoskeletal and signaling complexes, such as MAPK and PI3P-kinases, or Rho family of GTPases [13] . The reduction of chemotaxis in our in-vitro model may be due to the downregulation of one, or more, integrin functions.
After cellular activation, the pattern of MAC-1 expression on the surface of monocytes follows two waves. The first one originates from the storage pools, and is mobilized from the secretory vesicles to the outer membrane of the cell within a few minutes after the first chemotactic signaling, inducing a 4-to 12-fold increase over the basal level of the integrins [1] . The second wave appears after 24-72 h, and is the result of newly synthesized integrins. Since RT-PCR expression studies on CD18, CD11b and CD47 mRNA ruled out any modification of the expression rate of these genes caused by AGP treatment, we can hypothesize that the activity of AGP is likely to be related to the direct interfering with the exocytosis of the first wave of integrins, rather than connected to the 'de novo' synthesis of the second wave.
Another possible mechanism of action of AGP should not be ruled out. As an immunocalin, AGP may fulfil both functions of binding protein and immunomodulatory molecule. The results presented in this paper demonstrate that when high concentration of AGP is added to the chemotactic medium, it further decreases the migration rate of monocytes. While no binding properties of AGP toward C5a have been reported, it can be hypothesized that AGP molecules bind ZAS-generated C5a. This activity could be explained by the lipocalin structure of AGP, which allows the protein to interact with more than 300 different molecules [7, 16] . Therefore, it is possible that a further possible mechanism of action of AGP is that of dampening the inflammation by sequestering some of the mediators, thus reducing their biological availability in the inflammatory environment.
It remains to be elucidated why this effect is not evident in neutrophils, but only in monocytes.
In conclusion, the results of this investigation report for the first time the inhibitory effect of chemotaxis of AGP on bovine monocytes, and indicate that acute phase concentrations of AGP reduce the expression of CD18 on monocyte surfaces.
This finding may suggest a regulatory role for AGP in specific trafficking of monocytes from blood to tissues, and contribute to understanding the regulatory function of acute phase protein overexpression on blood cell migration during acute inflammation. Further studies are necessary to characterize the sub-population of monocytes, in order to investigate whether the activity is directed toward a specific population of monocytes.
